Idéal Investisseur
Français English
CAC 40 : Market closed
8 090,28 pts
-0.34%


Last updated : 15/09/2026 - 17h35

MAAT PHARMA news: financial news, earnings, stock moves and analysts

Live news related to MAAT PHARMA stock (FR0012634822): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.

The latest financial news on MAAT PHARMA mainly cover M&A activity et share price moves. The stock trades at €1,09 on Euronext Paris, down 56,66% at the last update. This page lists the articles published on MAAT PHARMA stock to track the share price, company announcements and any item likely to influence market perception.

Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
MAAT PHARMA
FR0012634822
Pharmaceuticals & Biotechnology / Biotechnology
1,09 € -56,66 %
High1,16 €
Low1,00 €
Last update : 15/09/2026 - 16:47:52 – Euronext Paris – 15 min delay.
Market closed

Latest MAAT PHARMA stock news

The Lyon-based biotech company has been informed of a negative voting trend from the European Committee for Medicinal Products for Human Use regarding…

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a negative opinion on Thursday regarding the conditi…

The stock of the Lyon-based biotech company plunges during the session, after a brief rebound on Friday. The stock is now trading at its lowest, as th…

However, the stock remains significantly distant from its pre-CHMP adverse signal levels, and the formal vote of the European committee remains the ce…

MaaT Pharma's stock experiences a sharp decline this Thursday midday, with the share price of the Lyon-based biotech falling to €2.97. The drop comes …

Lyon-based biotech company MaaT Pharma has been informed by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…

The stock of the Lyon-based biotech company recorded one of its strongest daily gains in several months, reaching 6.02 euros. This rebound follows a s…

MaaT Pharma announces the publication of the CHRONOS study, a multicenter retrospective analysis evaluating third-line treatments in 59 patients with …

MaaT Pharma releases its annual results for 2025 and updates on its microbiome therapy portfolio. The year 2026 is set to be pivotal with the ongoing …

MaaT Pharma announced on Monday the presentation of the final results of the pivotal ARES trial evaluating MaaT013 in acute gastrointestinal graft-ver…

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA